Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis
Liver fibrosis is characterized by the excessive deposition and accumulation of extracellular
matrix components, mainly collagens, and occurs in response to a broad spectrum of …
matrix components, mainly collagens, and occurs in response to a broad spectrum of …
The roles of epigenetic regulation and the tumor microenvironment in the mechanism of resistance to systemic therapy in hepatocellular carcinoma
K Oura, A Morishita, S Hamaya, K Fujita… - International Journal of …, 2023 - mdpi.com
Primary liver cancer is the sixth most common cancer and the third most common cause of
cancer-related deaths worldwide. Hepatocellular carcinoma (HCC) is a major histologic type …
cancer-related deaths worldwide. Hepatocellular carcinoma (HCC) is a major histologic type …
The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor …
P Zhang, C Qin, N Liu, X Zhou, X Chu, F Lv, Y Gu, L Yin… - Biomaterials, 2022 - Elsevier
Despite the remarkable success of immunotherapies over the past decade, their
effectiveness against triple-negative breast cancer (TNBC) is limited to a small subset of …
effectiveness against triple-negative breast cancer (TNBC) is limited to a small subset of …
USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization
J Tang, G Long, L **ao, L Zhou - Cell Death & Disease, 2023 - nature.com
Hepatocellular carcinoma (HCC) is the most common type of primary hepatic carcinoma,
which is a growing public health problem worldwide. One of the main genetic alterations in …
which is a growing public health problem worldwide. One of the main genetic alterations in …
Stabilization of TGF‐β receptor 1 by a receptor‐associated adaptor dictates feedback activation of the TGF‐β signaling pathway to maintain liver cancer stemness and …
K Liu, F Tian, X Chen, B Liu, S Tian, Y Hou… - Advanced …, 2024 - Wiley Online Library
Dysregulation of the transforming growth factor‐β (TGF‐β) signaling pathway regulates
cancer stem cells (CSCs) and drug sensitivity, whereas it remains largely unknown how …
cancer stem cells (CSCs) and drug sensitivity, whereas it remains largely unknown how …
Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
L Jiang, L Li, Y Liu, M Zhan, L Lu, S Yuan… - Frontiers in …, 2023 - frontiersin.org
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, and it
usually occurs following chronic liver disease. Although some progress has been made in …
usually occurs following chronic liver disease. Although some progress has been made in …
Wnt/β-Catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma
RWH Leung, TKW Lee - Cancers, 2022 - mdpi.com
Simple Summary Aberrant Wnt/β-catenin signaling has been reported to play crucial role in
pathogenesis of hepatocellular carcinoma (HCC). In this review, we focus on the regulatory …
pathogenesis of hepatocellular carcinoma (HCC). In this review, we focus on the regulatory …
β-Catenin signaling in hepatocellular carcinoma
C Xu, Z Xu, Y Zhang, M Evert… - The Journal of …, 2022 - Am Soc Clin Investig
Deregulated Wnt/β-catenin signaling is one of the main genetic alterations in human
hepatocellular carcinoma (HCC). Comprehensive genomic analyses have revealed that …
hepatocellular carcinoma (HCC). Comprehensive genomic analyses have revealed that …
Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7
Abstract Aims Sorafenib (Sora) represents one of the few effective drugs for the treatment of
advanced hepatocellular carcinoma (HCC), while resistance and cardiotoxicity limit its …
advanced hepatocellular carcinoma (HCC), while resistance and cardiotoxicity limit its …
A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC
H Yang, D Chen, Y Wu, H Zhou, W Diao, G Liu… - Cancer & Metabolism, 2023 - Springer
Background Hepatocellular carcinoma (HCC) is a principal type of liver cancer with high
incidence and mortality rates. Regorafenib is a novel oral multikinase inhibitor for second …
incidence and mortality rates. Regorafenib is a novel oral multikinase inhibitor for second …